Trial intelligence / Profile preview

VIP Study: Vitamins in First Episode Psychosis

NCT00202280Phase 3Completed

Sponsor
Melbourne Health
Start
Sep 2004
Primary completion
Sep 2006
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of folic acid, vitamin b12, pyridoxine in psychosis, sponsored by Melbourne Health. Started Sep 2004; status: completed.

02

Drugs

folic acidvitamin b12pyridoxine
03

Conditions

psychosis

Beyond the preview

Go deeper on NCT00202280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00202280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call